Etrolizumab (rhuMAb Beta7), a gut-selective anti-β7 integrin monoclonal antibody, targets the β7 subunit of α4β7 and αEβ7 integrins specifically, demonstrating affinity with K i values of 18 nM for Human α4β7 and 1800 pM for Human αEβ7-293.

2-(Octyloxy)acetic acid is a fungal metabolite that accumulates in the growth medium of Acinetobacter.

p-Hydroxy-5,6-dehydrokawain is isolated from Kawain.